Trigger-happy resident memory CD4(+) T cells inhabit the human lungs

A. E. Oja, B. Piet, C. Helbig, R. Stark, D. van der Zwan, H. Blaauwgeers, E. B. M. Remmerswaal, D. Amsen, R. E. Jonkers, P. D. Moerland, M. A. Nolte, R. A. W. van Lier, P. Hombrink

Research output: Contribution to journalArticleAcademicpeer-review

98 Citations (Scopus)

Abstract

Resident memory T cells (TRM) reside in the lung epithelium and mediate protective immunity against respiratory pathogens. Although lung CD8(+) TRM have been extensively characterized, the properties of CD4(+) TRM remain unclear. Here we determined the transcriptional signature of CD4(+) TRM, identified by the expression of CD103, retrieved from human lung resection material. Various tissue homing molecules were specifically upregulated on CD4(+) TRM, whereas expression of tissue egress and lymph node homing molecules were low. CD103(+) TRM expressed low levels of T-bet, only a small portion expressed Eomesodermin (Eomes), and although the mRNA levels for Hobit were increased, protein expression was absent. On the other hand, the CD103(+) TRM showed a Notch signature. CD4(+)CD103(+) TRM constitutively expressed high transcript levels of numerous cytotoxic mediators that was functionally reflected by a fast recall response, magnitude of cytokine production, and a high degree of polyfunctionality. Interestingly, the superior cytokine production appears to be because of an accessible interferon-γ (IFNγ) locus and was partially because of rapid translation of preformed mRNA. Our studies provide a molecular understanding of the maintenance and potential function of CD4(+) TRM in the human lung. Understanding the specific properties of CD4(+) TRM is required to rationally improve vaccine design.Mucosal Immunology advance online publication 15 November 2017; doi:10.1038/mi.2017.94
Original languageEnglish
Pages (from-to)654-667
JournalMucosal Immunology
Volume11
Early online date2017
DOIs
Publication statusPublished - 2018

Cite this